Replies to post #166325 on Biotech Values

[mr_o]

So does that theoretically cut ENTA's future revenue to 35% of current estimations? In other words, are current models based on royalties of 10% of 2 billion (for discussion sake) and will that now become 10% of (35% of 2 billion)?